Suppr超能文献

与消化不良症状相关的根除治疗有效性的预测因素。

Factors Predicting Effectiveness of Eradication Therapy for -Associated Dyspepsia Symptoms.

作者信息

Yasuda Kohei, Chinda Daisuke, Shimoyama Tadashi, Arai Tetsu, Akitaya Kazuki, Fujiwara Sae, Nomiya Hiroki, Sasaki Yoshio, Komai Kazuo, Sawada Yoshihiko, Saito Yoshiharu, Chiba Hironobu, Sakuraba Hirotake, Fukuda Shinsaku

机构信息

Department of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan.

Division of Endoscopy, Hirosaki University Hospital, Hirosaki 036-8563, Japan.

出版信息

Life (Basel). 2024 Jul 25;14(8):935. doi: 10.3390/life14080935.

Abstract

Functional dyspepsia is distinguishable from -associated dyspepsia. However, distinguishing -associated dyspepsia from functional dyspepsia before eradication is difficult. Therefore, in the present study, we aimed to investigate whether serum pepsinogen levels before eradication are associated with the amelioration of dyspepsia after successful eradication. Additionally, we examined the usefulness of serum pepsinogen levels and other factors in predicting dyspepsia outcomes. eradication was effective in 14 patients (Responders) and ineffective in 19 patients (Non-responders). The pepsinogen I/II ratio in Responders (3.4 ± 1.2) and Non-responders (2.3 ± 1.0) differed significantly ( = 0.006). The optimal cut-off pepsinogen I/II value was 2.3. Multivariate logistic regression analysis showed that the adjusted odds ratio for Non-responders was 26.1 (95% confidence interval: 2.0-338.0, = 0.012) for a pepsinogen I/II ratio ≤ 2.3 and 8.10 (95% confidence interval: 1.1-57.6, = 0.037) for smoking habits. The pepsinogen I/II ratio and smoking habits were associated with the effects of eradication on dyspeptic symptoms. Thus, the pepsinogen I/II ratio cut-off value can be used to identify patients likely to respond to eradication after the resolution of dyspeptic symptoms.

摘要

功能性消化不良可与幽门螺杆菌相关的消化不良相区分。然而,在根除幽门螺杆菌之前,将幽门螺杆菌相关的消化不良与功能性消化不良区分开来是困难的。因此,在本研究中,我们旨在调查根除幽门螺杆菌之前的血清胃蛋白酶原水平是否与成功根除幽门螺杆菌后消化不良症状的改善相关。此外,我们还研究了血清胃蛋白酶原水平和其他因素在预测消化不良结局方面的实用性。根除幽门螺杆菌对14例患者有效(反应者),对19例患者无效(无反应者)。反应者的胃蛋白酶原I/II比值(3.4±1.2)与无反应者(2.3±1.0)有显著差异(P=0.006)。最佳的胃蛋白酶原I/II截断值为2.3。多因素logistic回归分析显示,对于胃蛋白酶原I/II比值≤2.3的无反应者,调整后的比值比为26.1(95%置信区间:2.0-338.0,P=0.012);对于吸烟习惯,调整后的比值比为8.10(95%置信区间:1.1-57.6,P=0.037)。胃蛋白酶原I/II比值和吸烟习惯与根除幽门螺杆菌对消化不良症状的影响相关。因此,可以使用胃蛋白酶原I/II比值截断值来识别消化不良症状缓解后可能对根除幽门螺杆菌有反应的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cd2/11355128/941897a61b9f/life-14-00935-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验